United Therapeutics
+$3.07 (+1.48%) As of 6:21 PM UTC today
Why Robinhood?
You can buy or sell UTHR and other stocks, options, and ETFs commission-free!
About UTHR
United Therapeutics Corp. operates as a biotechnology company, which engages in the development and commercialization of products for patients with chronic and life-threatening diseases. The firm markets and sells commercial therapies to treat pulmonary arterial hypertension and high-risk neuroblastoma.
CEO
Martine A. Rothblatt
Employees
950
Headquarters
Silver Spring, Maryland
Founded
1996
Market Cap
9.28B
Price-Earnings Ratio
17.66
Dividend Yield
—
Average Volume
547.47K
High Today
$211.58
Low Today
$207.74
Open Price
$208.63
Volume
153.05K
52 Week High
$211.58
52 Week Low
$98.37
Analyst Ratings
80%
of 10 ratings
Buy
80%
Hold
10%
Sell
10%
UTHR Earnings
$0.00
$1.29
$2.59
$3.88
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Estimated
— per share
Actual
Expected Apr 28, Pre-Market